Mailman researchers have found that the grandchildren of women who used DES during pregnancy were 36 percent more likely to have ADHD.
The Mothers Center is a new space that will provide comprehensive, multidisciplinary care—focused on the mother—before, during, and after a high-risk pregnancy.
RhoGAM, a drug developed in the 1960s by Columbia University physicians, prevents one of the most severe and devastating diseases affecting fetuses and newborn babies and is still in use today.
After a rocky pregnancy, Donna, a patient of ColumbiaDoctors, describes how Columbia’s obstetrics team helped protect her and her baby, Grace.
Twin pregnancies in women 35 and older do not carry substantially higher risks of preterm birth, fetal death, or infant death compared with twin pregnancies in younger women.
Certain women with preeclampsia are more likely to have a pregnancy-related stroke, finds a new study led by Columbia neurologists.